We analyzed the correlation between CLDN18.2 and other immune checkpoint inhibitors in the tumor core; unfortunately, we did not observe any correlation with PD-1, PD-L1, CTLA-4, LAG-3, or TIM-3 (Additional file 2: Fig. S3). Here, HAVCR2 is linked to neoplasm.